Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/617
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
ul Qamar, M
Alqahtani, S
Alamri, M
Chen, L
Acceso Abierto
Atribución-NoComercial-SinDerivadas
Highlights • SARS-CoV-2 3CL pro is conserved, share 99.02% sequence identity with SARS-CoV 3CL pro and together with 12 point-mutations. • Mutations disrupt important hydrogen bonds and alter the receptor binding site of SARS-CoV-2 3CL pro . • Medicinal plants phytochemicals were proved potential anti-COVID-19 druggable candidates.
Journal of Pharmaceutical Analysis
2020
Preimpreso
https://coronavirus.1science.com/item/aac93c166fe3b9058b9d7ea387c1fa18d3fbb0d0
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
100511.pdf3.21 MBAdobe PDFView/Open